Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Exp Dermatol ; 19(9): 813-20, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20545756

RESUMEN

Azelaic acid (AzA), a nine-carbon dicarboxylic acid, is an agent for the topical treatment of acne. It has also been shown to be effective in rosacea; however, the mechanism of action has not been clarified. Because inflammation is a common feature of both conditions, we investigated the effects of azelaic acid on the inflammatory response of normal human keratinocytes to ultraviolet B light, which is a photosensitizer agent in rosacea. AzA, at 20 mM, a concentration achievable following topical application of a 15% gel, suppresses ultraviolet B light-induced interleukins-1beta, -6 and tumor necrosis factor-alpha mRNA expression and protein secretion. Mechanistically, azelaic acid significantly reduced the ultraviolet B light-induced nuclear translocation of nuclear factor kB p65 subunit and the phosphorylation of the p38 mitogen and stress-activated protein kinase. Moreover, as peroxisome proliferators-activated receptor gamma, (PPARgamma) which has a crucial role in the control of inflammation, is activated by fatty acids and products of lipid peroxidation, we further investigated the effect of azelaic acid on the expression of this nuclear receptor. AzA induced peroxisome proliferators-activated receptor-gamma mRNA and its transcriptional activity. The PPARgamma antagonist GW9662 abrogated the inhibitory effects of AzA on the UVB-induced pro-inflammatory cytokines release and on the cell proliferation. Our study provides new insights into the molecular mechanisms of the activity of azelaic acid and lands additional evidences for its therapeutic effects on inflammatory skin diseases, such as rosacea.


Asunto(s)
Acné Vulgar/tratamiento farmacológico , Fármacos Dermatológicos/farmacología , Ácidos Dicarboxílicos/farmacología , Queratinocitos/efectos de los fármacos , FN-kappa B/metabolismo , Células Cultivadas , Citocinas/metabolismo , Fármacos Dermatológicos/uso terapéutico , Ácidos Dicarboxílicos/uso terapéutico , Evaluación Preclínica de Medicamentos , Genes Reporteros , Humanos , Queratinocitos/metabolismo , Queratinocitos/efectos de la radiación , PPAR gamma/agonistas , PPAR gamma/genética , PPAR gamma/metabolismo , Fosforilación/efectos de los fármacos , ARN Mensajero/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Rosácea/tratamiento farmacológico , Transcripción Genética/efectos de los fármacos , Rayos Ultravioleta , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
2.
Growth Factors ; 27(6): 448-55, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19919532

RESUMEN

Bovine colostrum represents a rich source of growth factors, which are known to play a central role in wound healing. The aim of our study was to investigate the possible mitogenic and motogenic effects induced by colostrum on human keratinocytes. Cell proliferation evaluated by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide test and 5-Bromo-2'-deoxyuridine incorporation revealed that colostrum exerts a growth promoting activity. Scratch assay and immunofluorescence of actin cytoskeleton showed its effectiveness also in inducing cell migration. Furthermore, colostrum treatment increases the levels of tyrosine phosphorylated proteins and the activated forms of the extracellular signal-regulated kinases 1 and 2 and such effects appear to be repressed by the tyrosine kinase inhibitor genistein. Our results indicate that the biological activities of colostrum are specifically mediated by the growth factor-induced activation of tyrosine kinase receptors and underline the relevance of the synergistic action exerted by the growth factors in stimulating keratinocyte proliferation and migration essential for tissue repair.


Asunto(s)
Movimiento Celular/fisiología , Proliferación Celular/efectos de los fármacos , Calostro/fisiología , Queratinocitos/efectos de los fármacos , Animales , Bovinos , Línea Celular , Femenino , Regulación de la Expresión Génica , Humanos , Queratinocitos/citología , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Embarazo , Proteínas Tirosina Quinasas Receptoras/metabolismo , Cicatrización de Heridas/fisiología
3.
Eur J Dermatol ; 19(5): 469-73, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19505863

RESUMEN

Two patients with a generalized, progressive dyschromatosis disorder are described and investigated as a model to study the role of fibroblast-derived mediators on skin pigmentation. The patients (father and daughter) had had a widespread hyperpigmentation since early life which then progressively worsened with the appearance of hyperpigmented macules, café-au-lait macules and freckles, also involving the lips, palms and soles, intermixed with small hypopigmented spots. These features resembled those of familial progressive hyperpigmentation (FPH). Histology revealed a normal epidermis with pronounced keratinocyte hyperpigmentation and the presence of dermal melanophages. Ultrastructural analysis showed basal and suprabasal keratinocytes enriched in melanosome complexes. Immunohistochemical staining displayed an increased expression of hepatocyte growth factor (HGF), stem cell factor (SCF) and keratinocyte growth factor (KGF) in fibroblast-like cells of the upper dermis in hyperpigmented lesions of both patients, compared to control healthy skin. Our data suggest that a persistent activation of fibroblasts abnormally stimulating melanocyte functions is involved in hyperpigmentation disorders.


Asunto(s)
Factor 7 de Crecimiento de Fibroblastos/fisiología , Fibroblastos/química , Factor de Crecimiento de Hepatocito/fisiología , Hiperpigmentación/genética , Factor de Células Madre/fisiología , Adulto , Femenino , Factor 7 de Crecimiento de Fibroblastos/análisis , Factor de Crecimiento de Hepatocito/análisis , Humanos , Hiperpigmentación/etiología , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Factor de Células Madre/análisis
4.
Exp Dermatol ; 17(2): 115-24, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18047584

RESUMEN

Aberrant gap junctional intercellular communication (GJIC) has been implicated in tumor development and progression. UltravioletA (UVA)-induced oxidative stress has been associated with skin carcinogenesis. We report a potential link between GJIC and the cellular stress response induced by UVA in normal human keratinocytes (NHK). In this study, UVA irradiation (10 J/cm(2)) compromised GJIC integrity in absence of cytotoxic effects as demonstrated by the absence of cell death and by the reversibility of GJIC down-regulation. Inhibition of communication by UVA was associated with hyperphosphorylation and decreased expression of connexin43 (Cx43), the most abundant gap junction protein expressed by keratinocytes. Cx43 hyperphosphorylation induced by UVA is, at least in part, mediated through mitogen-activated protein kinase (MAPK) activation as Ser279 and Ser282 sites, two downstream direct targets of p38 MAPK were found to be phosphorylated after UVA treatment. However, inhibition of p38 MAPK activity did not significantly protect from cell-cell communication inhibition because of a strong cellular cytotoxicity observed with SB202190 and SB203580, two selective inhibitors of p38 MAPK, in combination with UVA that compromises the outcome of dye transfer assay. By contrast, in Hacat cell line, inhibition of p38 activity reduced both phosphorylation and degradation of Cx43, demonstrating that these events are correlated.


Asunto(s)
Comunicación Celular/efectos de la radiación , Uniones Comunicantes/efectos de la radiación , Queratinocitos/metabolismo , Rayos Ultravioleta , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo , Comunicación Celular/fisiología , Membrana Celular/efectos de la radiación , Células Cultivadas , Conexina 43/genética , Conexina 43/metabolismo , Regulación hacia Abajo/efectos de la radiación , Uniones Comunicantes/fisiología , Humanos , Queratinocitos/efectos de la radiación , Fosforilación/efectos de la radiación , Especies Reactivas de Oxígeno/metabolismo , Transducción de Señal/efectos de la radiación , Proteínas Quinasas p38 Activadas por Mitógenos/genética
5.
J Invest Dermatol ; 125(6): 1190-9, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16354189

RESUMEN

Melanogenesis and melanosome transfer from the melanocytes to the neighboring keratinocytes are induced by ultraviolet radiation and modulated by autocrine and paracrine factors. Keratinocyte growth factor (KGF/fibroblast growth factor (FGF)7) is a paracrine mediator of human keratinocyte growth and differentiation. We evaluated the influence of KGF on melanosome transfer in co-cultures of keratinocytes and melanocytes. Immunofluorescence analysis using anti-tyrosinase and anti-human cytokeratin antibodies, phagocytic assays using fluorescent latex beads, and ultrastructural analysis indicated that KGF is able to induce melanosome transfer acting only on the recipient keratinocytes and as a consequence of a general role of KGF in the promotion of the phagocytic process. Inhibition of proteinase-activated receptor-2, to block the Rho-dependent phagocytic pathway, or of the Src family tyrosine kinases, to inhibit the Rac-dependent pathway, showed that KGF promotes phagocytosis through both mechanisms. Increased expression of the KGF receptor (KGFR) on the keratinocytes by transfection led to increased phagocytosis of latex beads following KGF treatment, suggesting that the KGF effect is directly mediated by KGFR expression and activation. Moreover, confocal microscopic analysis revealed that KGFR localize in phagosomes during KGF-induced phagocytosis, suggesting a direct role of the receptor in regulating both the early steps of uptake and the intracellular traffic of the phagosomes.


Asunto(s)
Factor 7 de Crecimiento de Fibroblastos/farmacología , Queratinocitos/fisiología , Melanocitos/fisiología , Melanosomas/fisiología , Fagocitosis/efectos de los fármacos , Adulto , Línea Celular , Femenino , Humanos , Queratinocitos/citología , Queratinocitos/efectos de los fármacos , Melanocitos/citología , Melanocitos/efectos de los fármacos , Melanosomas/efectos de los fármacos , Pigmentación de la Piel/fisiología , Transfección , alfa-MSH/farmacología
6.
J Invest Dermatol ; 134(4): 1001-1011, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24166135

RESUMEN

Peroxisome proliferator-activated receptor γ (PPARγ) antagonizes inflammatory signals by interfering with NF-κB nuclear translocation. Consistently, PPARγ agonists have been proposed in various inflammatory skin disorders, but their wide use has been limited by severe side effects. Classes of compounds with specific PPARγ agonism have been designed to selectively target inflammatory pathways. Among these compounds, GED-0507-34L has been developed and recently used in phase II clinical trials for inflammatory bowel diseases. This study was aimed at assessing the role of GED-0507-34L in preclinical models of inflammatory skin diseases. The compound modulated PPARγ function and suppressed the inflammatory process inhibiting NF-κB nuclear translocation with the consequent reduction of inflammatory cytokines expression, such as IL-6, IL-8, IL-12, IL-21, IL-23, tumor necrosis factor-α (TNF-α), and cyclooxygenase-2 (COX-2) in normal human keratinocytes and lymphocytes treated with lipopolysaccharide (LPS) or TNF-α. Moreover, an altered proliferation and expression of differentiation markers induced by TNF-α were also counteracted. In psoriasis-like skin lesions elicited in mice by IL-21, topical application of GED-0507-34L reduced cellular infiltrate and epidermal hyperplasia, normalizing the differentiation process. The results indicate that GED-0507-34L possesses anti-inflammatory properties useful for the management of patients with inflammatory skin diseases including psoriasis. Phase I trial on patients is ongoing.


Asunto(s)
Transporte Activo de Núcleo Celular/efectos de los fármacos , Compuestos de Anilina/uso terapéutico , Inflamación/tratamiento farmacológico , PPAR gamma/metabolismo , Fenilpropionatos/uso terapéutico , Propionatos/uso terapéutico , Piel/patología , Compuestos de Anilina/química , Animales , Biopsia , Adhesión Celular , Proliferación Celular , Células Cultivadas , Ciclooxigenasa 2/metabolismo , Citocinas/metabolismo , Epidermis/metabolismo , Humanos , Queratinocitos/citología , Lipopolisacáridos/química , Ratones , Ratones Endogámicos C57BL , FN-kappa B/metabolismo , Fenilpropionatos/química , Propionatos/química , Unión Proteica , Psoriasis/metabolismo , Interferencia de ARN , Piel/efectos de los fármacos
7.
Pigment Cell Melanoma Res ; 26(1): 113-27, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22863076

RESUMEN

We have discovered a new α-melanocyte stimulating hormone (α-MSH)/peroxisome proliferator activated receptor-γ (PPAR-γ) connection in B16-F10 cells. Both PPAR-γ up-regulation and its induction as an active transcription factor were observed in response to α-MSH. The α-MSH/PPAR-γ connection influenced both pigmentation and proliferation. The forskolin-stimulated cAMP/PKA pathway was not able to induce either PPAR-γ translocation into the nucleus or PPAR-γ transcriptional activity. As the melanocortin-1 receptor, the specific receptor for the α-MSH, is a G-protein coupled receptor, we wondered whether the phosphatidylinositol [PI(4,5)P(2) /PLC(ß) ] signal pathway was involved in mediating the α-MSH-dependent PPAR-γ activation. Employing inhibitors of PI(4,5)P(2) /PLC(ß) pathway, the results of our experiments suggested that this pathway was promoted by α-MSH and that α-MSH played a role in mediating PPAR-γ activation. We have demonstrated, for the first time, that α-MSH induces the PI(4,5)P(2) /PLC(ß) pathway, through analysis of the basic steps of the pathway. The α-MSH effect on PPAR-γ was independent of animal species and was not correlated with the physio-pathological status.


Asunto(s)
Melanoma Experimental/metabolismo , PPAR gamma/metabolismo , Neoplasias Cutáneas/metabolismo , alfa-MSH/farmacología , Animales , Ácido Araquidónico/metabolismo , Calcio/metabolismo , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Núcleo Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Proliferación Celular/efectos de los fármacos , AMP Cíclico/metabolismo , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Diglicéridos/metabolismo , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Células HeLa , Humanos , Hidrólisis/efectos de los fármacos , Fosfatos de Inositol/metabolismo , Melanoma Experimental/genética , Melanoma Experimental/patología , Ratones , PPAR gamma/genética , Fosfolipasa C beta/metabolismo , Transporte de Proteínas/efectos de los fármacos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genética , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/patología
8.
J Invest Dermatol ; 132(4): 1196-205, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22297637

RESUMEN

Interest in colorless intermediates of melanocyte metabolism has traditionally been related to their role as melanin precursors, though several lines of evidence scattered in the literature suggested that these compounds may exert an antioxidant and protective function per se unrelated to pigment synthesis. Herein, we disclose the remarkable protective and differentiating effects of 5,6-dihydroxyindole-2-carboxylic acid (DHICA), a diffusible dopachrome tautomerase (DCT)-dependent eumelanin intermediate, on primary cultures of human keratinocytes. At micromolar concentrations, DHICA induced: (a) time- and dose-dependent reduction of cell proliferation without concomitant toxicity; (b) enhanced expression of early (spinous keratins K1 and K10 and envelope protein involucrin) and late (loricrin and filaggrin) differentiation markers; (c) increased activities and expression of antioxidant enzymes; and (d) decreased cell damage and apoptosis following UVA exposure. The hitherto unrecognized role of DHICA as an antiproliferative, protective, and antiapoptotic endogenous cell messenger points to a reappraisal of the biological functions of melanocytes and DCT in skin homeostasis and photoprotection beyond the mere provision of melanin pigments, and provides, to our knowledge, a previously unreported possible explanation to the higher resistance of the dark-skinned eumelanic phenotypes to sunburn and skin cancer.


Asunto(s)
Comunicación Celular/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Células Epidérmicas , Epidermis/efectos de los fármacos , Indoles/farmacología , Melaninas/metabolismo , Apoptosis/efectos de los fármacos , Apoptosis/efectos de la radiación , Comunicación Celular/fisiología , Células Cultivadas , Relación Dosis-Respuesta a Droga , Epidermis/metabolismo , Proteínas Filagrina , Humanos , Proteínas de Filamentos Intermediarios/metabolismo , Queratinocitos/citología , Queratinocitos/efectos de los fármacos , Queratinocitos/metabolismo , Queratinas/metabolismo , Melanocitos/citología , Melanocitos/efectos de los fármacos , Melanocitos/metabolismo , Proteínas de la Membrana/metabolismo , Receptores Activados del Proliferador del Peroxisoma/metabolismo , Precursores de Proteínas/metabolismo , Factores de Tiempo
9.
PLoS One ; 7(10): e48097, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23094106

RESUMEN

In filamentous fungi, peroxisomes are crucial for the primary metabolism and play a pivotal role in the formation of some secondary metabolites. Further, peroxisomes are important site for fatty acids ß-oxidation, the formation of reactive oxygen species and for their scavenging through a complex of antioxidant activities. Oxidative stress is involved in different metabolic events in all organisms and it occurs during oxidative processes within the cell, including peroxisomal ß-oxidation of fatty acids. In Aspergillus flavus, an unbalance towards an hyper-oxidant status into the cell is a prerequisite for the onset of aflatoxin biosynthesis. In our preliminary results, the use of bezafibrate, inducer of both peroxisomal ß-oxidation and peroxisome proliferation in mammals, significantly enhanced the expression of pex11 and foxA and stimulated aflatoxin synthesis in A. flavus. This suggests the existence of a correlation among peroxisome proliferation, fatty acids ß-oxidation and aflatoxin biosynthesis. To investigate this correlation, A. flavus was transformed with a vector containing P33, a gene from Cymbidium ringspot virus able to induce peroxisome proliferation, under the control of the promoter of the Cu,Zn-sod gene of A. flavus. This transcriptional control closely relates the onset of the antioxidant response to ROS increase, with the proliferation of peroxisomes in A. flavus. The AfP33 transformant strain show an up-regulation of lipid metabolism and an higher content of both intracellular ROS and some oxylipins. The combined presence of a higher amount of substrates (fatty acids-derived), an hyper-oxidant cell environment and of hormone-like signals (oxylipins) enhances the synthesis of aflatoxins in the AfP33 strain. The results obtained demonstrated a close link between peroxisome metabolism and aflatoxin synthesis.


Asunto(s)
Aflatoxinas/biosíntesis , Aspergillus flavus/genética , Ácidos Grasos/metabolismo , Proteínas Fúngicas/genética , Regulación Fúngica de la Expresión Génica/efectos de los fármacos , Peroxisomas/metabolismo , Antioxidantes/metabolismo , Aspergillus flavus/efectos de los fármacos , Aspergillus flavus/metabolismo , Bezafibrato/farmacología , Proteínas Fúngicas/metabolismo , Vectores Genéticos , Hipolipemiantes/farmacología , Metabolismo de los Lípidos/efectos de los fármacos , Oxidación-Reducción , Estrés Oxidativo , Regiones Promotoras Genéticas , Especies Reactivas de Oxígeno/metabolismo , Superóxido Dismutasa/genética , Superóxido Dismutasa/metabolismo , Tombusvirus/genética
10.
Pigment Cell Melanoma Res ; 23(2): 263-75, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20067588

RESUMEN

We demonstrated a direct correlation between melanogenic and catalase activities on in vitro and ex vivo models. Here, we investigated whether the stimulation of Melanocortin-1 Receptor (MC1R) could influence catalase expression, activity and cellular localization. For this purpose, we treated B16-F0 melanoma cells with alpha-Melanocyte Stimulating Hormone (alpha-MSH) and we showed a rapid induction of catalase through a cAMP/PKA-dependent, microphthalmia-associated transcription factor (MITF) independent mechanism, acting at post-transcriptional level. Moreover, alpha-MSH promoted a partial re-distribution of catalase to the cell periphery and dendrites. This work strengthens the correlation between melanogenesis and anti-oxidants, demonstrating the induction of catalase in response to a melanogenic stimulation, such as alpha-MSH-dependent MC1R activation. Moreover, this study highlights catalase regulatory mechanisms poorly known, and attributes to alpha-MSH a protective role in defending melanocytes, and possibly keratinocytes, not only on the basis of its pigmentary action, but also for its capacity to stimulate a quick anti-oxidant defence.


Asunto(s)
Catalasa/metabolismo , Membrana Celular/efectos de los fármacos , Dendritas/efectos de los fármacos , Melanoma/metabolismo , Receptor de Melanocortina Tipo 1/metabolismo , alfa-MSH/farmacología , Animales , Catalasa/biosíntesis , Membrana Celular/enzimología , AMP Cíclico/metabolismo , Proteína Quinasa Tipo II Dependiente de AMP Cíclico/metabolismo , Dendritas/enzimología , Melanoma/patología , Ratones , Transporte de Proteínas/efectos de los fármacos , Receptor de Melanocortina Tipo 1/agonistas , Relación Estructura-Actividad , Células Tumorales Cultivadas
11.
J Dermatol Sci ; 54(2): 106-13, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19250802

RESUMEN

BACKGROUND: Exposure to ultraviolet (UV) radiation causes a complex cellular response, mostly mediated by the production of reactive oxygen species (ROS), which can be counteracted by exogenous treatments and endogenous mechanisms with anti-oxidant and scavenger properties. Keratinocyte growth factor (KGF/FGF7), a member of the fibroblast growth factor family, promotes epithelial growth and differentiation and is involved in cell survival after oxidant injuries. OBJECTIVE: We analyzed the role of KGF in the control of intracellular ROS production and oxidative stress after UVB exposure on KGF receptor (KGFR) transfected cells and human immortalized and primary keratinocytes. METHODS: We assessed the intracellular ROS production measuring the intensity of the oxidation-sensitive fluorescent probe 2',7'-dichlorofluorescein diacetate (DCFH-DA) by confocal microscopy, as well as the catalase activity by spectrophotometric assay. Moreover, morphological and biochemical analysis of actin cytoskeleton reorganization was evaluated as a further marker of oxidative damage. RESULTS: Our data show that KGF significantly reduces intracellular ROS generation in response to UVB, preserves the decrease of catalase activity and prevents actin cytoskeleton rearrangement. CONCLUSION: Our results provide a further evidence that KGF may be crucial for an efficient skin photoprotection, demonstrating a direct role for KGF in the reduction of intracellular ROS content following UVB exposure.


Asunto(s)
Actinas/metabolismo , Catalasa/metabolismo , Factor 7 de Crecimiento de Fibroblastos/fisiología , Queratinocitos/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Receptor Tipo 2 de Factor de Crecimiento de Fibroblastos/metabolismo , Actinas/efectos de los fármacos , Actinas/efectos de la radiación , Animales , Catalasa/efectos de los fármacos , Catalasa/efectos de la radiación , Línea Celular , Citoesqueleto/efectos de los fármacos , Citoesqueleto/metabolismo , Citoesqueleto/efectos de la radiación , Regulación hacia Abajo/efectos de los fármacos , Factor 7 de Crecimiento de Fibroblastos/farmacología , Humanos , Queratinocitos/efectos de los fármacos , Queratinocitos/efectos de la radiación , Ratones , Células 3T3 NIH , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/efectos de la radiación , Receptor Tipo 2 de Factor de Crecimiento de Fibroblastos/agonistas , Transfección , Rayos Ultravioleta
12.
J Invest Dermatol ; 128(3): 558-67, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17882267

RESUMEN

The transfer of melanin from melanocytes to keratinocytes is upregulated by UV radiation and modulated by autocrine and paracrine factors. Among them, the keratinocyte growth factor (KGF/FGF7) promotes melanosome transfer acting on the recipient keratinocytes through stimulation of the phagocytic process. To search for possible differences in the melanosome uptake of keratinocytes from different skin color, we analyzed the uptake kinetics and distribution pattern of fluorescent latex beads in primary cultures of light and dark skin-derived keratinocytes stimulated with KGF and we compared the direct effect of KGF on the melanosome transfer in co-cultures of human primary melanocytes with light and dark keratinocytes. KGF-promoted melanosome transfer was more significant in light keratinocytes compared to dark, due to an increased expression of KGF receptor in light skin keratinocytes. Colocalization studies performed by confocal microscopy using FITC-dextran as a phagocytic marker and fluorescent beads as well as inhibition of particle uptake by cytochalasin D, revealed that beads internalization induced by KGF occurs via actin-dependent phagocytosis. 3D image reconstruction by fluorescence microscopy and ultrastructural analysis through transmission electron microscopy showed differences in the distribution pattern of the beads in light and dark keratinocytes, consistent with the different melanosome distribution in human skin.


Asunto(s)
Factor 7 de Crecimiento de Fibroblastos/metabolismo , Queratinocitos/metabolismo , Melanosomas/metabolismo , Fagocitosis/fisiología , Pigmentación de la Piel/fisiología , Adulto , Comunicación Autocrina , Células Cultivadas , Técnicas de Cocultivo , Dextranos/farmacocinética , Femenino , Factor 7 de Crecimiento de Fibroblastos/farmacología , Fluoresceína-5-Isotiocianato/análogos & derivados , Fluoresceína-5-Isotiocianato/farmacocinética , Humanos , Recién Nacido , Queratinocitos/citología , Masculino , Melaninas/metabolismo , Melanocitos/citología , Melanocitos/metabolismo , Microesferas , Comunicación Paracrina , Fagocitosis/efectos de los fármacos , Receptor Tipo 2 de Factor de Crecimiento de Fibroblastos/metabolismo
13.
Exp Cell Res ; 313(9): 1758-77, 2007 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-17449030

RESUMEN

Keratinocyte growth factor (KGF/FGF7) and fibroblast growth factor 10 (FGF10/KGF2) regulate keratinocyte proliferation and differentiation by binding to the tyrosine kinase KGF receptor (KGFR). KGF induces keratinocyte motility and cytoskeletal rearrangement, whereas a direct role of FGF10 on keratinocyte migration is not clearly established. Here we analyzed the motogenic activity of FGF10 and KGF on human keratinocytes. Migration assays and immunofluorescence of actin cytoskeleton revealed that FGF10 is less efficient than KGF in promoting migration and exerts a delayed effect in inducing lamellipodia and ruffles formation. Both growth factors promoted phosphorylation and subsequent membrane translocation of cortactin, an F-actin binding protein involved in cell migration; however, FGF10-induced cortactin phosphorylation was reduced, more transient and delayed with respect to that promoted by KGF. Cortactin phosphorylation induced by both growth factors was Src-dependent, while its membrane translocation and cell migration were blocked by either Src and PI3K inhibitors, suggesting that both pathways are involved in KGF- and FGF10-dependent motility. Furthermore, siRNA-mediated downregulation of cortactin inhibited KGF- and FGF10-induced migration. These results indicate that cortactin is involved in keratinocyte migration promoted by both KGF and FGF10.


Asunto(s)
Actinas/metabolismo , Movimiento Celular/fisiología , Cortactina/metabolismo , Factor 10 de Crecimiento de Fibroblastos/metabolismo , Factor 7 de Crecimiento de Fibroblastos/metabolismo , Queratinocitos/metabolismo , Citoesqueleto de Actina/efectos de los fármacos , Citoesqueleto de Actina/metabolismo , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/fisiología , Línea Celular , Membrana Celular/metabolismo , Movimiento Celular/efectos de los fármacos , Citoplasma/efectos de los fármacos , Citoplasma/metabolismo , Citoesqueleto/efectos de los fármacos , Citoesqueleto/metabolismo , Regulación hacia Abajo/genética , Inhibidores Enzimáticos/farmacología , Factor 10 de Crecimiento de Fibroblastos/farmacología , Factor 7 de Crecimiento de Fibroblastos/farmacología , Técnica del Anticuerpo Fluorescente , Humanos , Queratinocitos/efectos de los fármacos , Paxillin/metabolismo , Fosforilación/efectos de los fármacos , Transporte de Proteínas/fisiología , Seudópodos/efectos de los fármacos , Seudópodos/metabolismo , ARN Interferente Pequeño/genética , Factores de Tiempo , Cicatrización de Heridas/fisiología , Familia-src Quinasas/metabolismo
14.
Exp Dermatol ; 15(10): 762-8, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16984257

RESUMEN

The aetiopathogenic mechanism underlying clear cell acanthoma (CCA) is not completely clear and it has been postulated that CCA and psoriasis may have a similar pathogenesis because of the common features shared by the two diseases. As it has been recently demonstrated that in psoriatic lesions the paracrine epithelial growth factors [keratinocyte growth factor (KGF)/fibroblast growth factor (FGF)-7 and FGF-10] are involved in promoting and sustaining the keratinocyte hyperproliferation, the aim of this study was to analyse the expression of KGF on CCA lesions and to search for a role of this growth factor in CCA pathogenesis. Immunohistochemical analysis showed an up-modulation of KGF in CCA, although the immunostaining was variable among the different samples collected. Positive immunoreactivity for KGF was detected mainly on dermal areas where the inflammatory infiltrate was more pronounced suggesting a relationship between lymphocyte activation and KGF up-modulation. Real-time quantitative RT-PCR assay performed on mRNA extracted from formalin-fixed paraffin-embedded CCA and normal skin (NS) samples further demonstrated the overexpression of the KGF/FGF-7 gene in all CCA samples compared with NS. Moreover, the evaluation by immunohistochemistry of KGF receptor distribution, the high-affinity tyrosine kinase receptor for KGF, showed a down-modulation of this receptor, as previously reported in the presence of increased levels of KGF. Taken together these results suggest the inflammatory nature of CCA and further support the hypothesis that this disease may represent, like psoriasis, an inflammatory dermatosis in which KGF up-modulation may be responsible for keratinocyte hyperproliferation and may represent a new common feature of both diseases.


Asunto(s)
Acantoma/metabolismo , Factor 7 de Crecimiento de Fibroblastos/metabolismo , Receptor Tipo 2 de Factor de Crecimiento de Fibroblastos/metabolismo , Neoplasias Cutáneas/metabolismo , Acantoma/genética , Acantoma/patología , Anciano , Proliferación Celular , Receptores ErbB/genética , Receptores ErbB/metabolismo , Factor 7 de Crecimiento de Fibroblastos/genética , Regulación Neoplásica de la Expresión Génica , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Receptor Tipo 2 de Factor de Crecimiento de Fibroblastos/genética , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA